Image provided by: Texas A&M University
About The Battalion. (College Station, Tex.) 1893-current | View Entire Issue (March 8, 2001)
Page 6 scienc TECHN lU rsday, March 8, Thursday, Ma THE BATTALION House votes to pay expenses for living organ donations "j. WASHINGTON (AP) — Hoping toencourage living Americans to do nate a kidney or even a section of liv er, the House voted unanimously on Wednesday to help pay donors’ trav el and other expenses. ' Living donations doubled during the 1990s as medical techniques im proved and the demand for organs became more acute, while donations after death grew very slowly. “It’s a very simple, direct kind of program. If you’re willing to help and you’re willing to donate, we’re going to help you,” said Rep. Karen Thurman, D-Fla. The legislation, approved 404-0, with 31 members absent, also pro vides for grants to states to try to in crease donations after death. The debate and vote were in stark contrast to the last time the House considered the issue of organ dona tion, when lawmakers were sharply divided over how available organs should be distributed. Most members supported the cur rent system, which gives preference to patients in the local areas; others argued that organs should be offered to the sickest patients first, even if they live outside the area. That debate is largely on hold for now, and much of the attention has turned to donation, where there is more consensus. The legislation ap proved Wednesday pulled out the noncontroversial aspects of the 1999 House bill. The legislation authorizes $5 mil lion per year for grants to states and organ banks to reimburse travel and We want people to be heroes, but we don't want them to be martyrs." — Arthur Caplan director of Center for Bioethics at the University of Pennsylvania other expenses for certain living donors. It also allows for $ 15 million for grants that would help states de velop registries of people who wish to donate and for public education about donation. That money still must be appropriated through the an nual budget process. Health and Human Services Sec retary Tommy Thompson, who has promised to offer his own program promoting organ donation, said in a letter that the Bush administration supports the legislation. It now heads to the Senate, where Sen. Richard Durbin, D-Ill., is work ing on a similar bill that would put more emphasis on encouraging donor registries. Federal law prohibits paying for organs, and an effort in Pennsylvania to reimburse donor families for their funeral expenses was scuttled amid legal concerns about the payments. The House bill takes a similar ap proach, and both efforts represent small steps toward paying for organs, said Arthur Caplan, director of the Center for Bioethics at the Universi ty of Pennsylvania. But both are eth ically sound, he said. “We should all be concerned that we not slide for paying for expenses to just paying people for their parts,” he said. But he said there is nothing wrong with helping people who make this choice on their own. “We want people to be heroes, but we don’t want them to be martyrs,” Caplan said. While some contend government should pay for organs, given their in credible value, Caplan and others worry that could erode support for donation and create situations in which people are pressured to donate against their wishes. More than 74,000 people await transplants, and more than 6,100 die each year waiting. The number wait ing and the number of deaths have each more than tripled since 1990. Most donations come from peo ple who have died. But in 1999, there were 4,712 living organ donors. Most of them donated one of their two kidneys, though donations of a piece of liver are becoming more common, with 218dn 1999. Only one kidney is needed for normal function, and the two pieces of a divided liver can each regener ate to become full livers. Under the national transplant network’s rules, kidney donors who see their remain ing kidney fail are given preference on the waiting list. Of the living donors, most are family members, principally sib lings. Twenty percent came from people unrelated to the recipient in 1999. The bill would allow states to pay donors for travel and subsistence ex penses if the donor and the recipient live in different states and if the recip ient has surgery at the closest trans plant center. Those who donate organs to patients with annual incomes over $35,000 would not be eligible. NT Aspirin may redueomn* ovarian cancer r NASHVILLE, Tenn. (AP) — Women who take aspirin at least three times a week for an extended period may decrease their risk of ovarian cancer by as much as 40 percent, a new study shows. The study’s findings parallel previous studies on the preventative powers of aspirin for heart disease and cancers that begin in the colon or rectum. Women should realize that long term use carries risks, including ul cers-, says the lead author, Dr. Arslan Akhmedkhanov of New York Uni versity School of Medicine. The study, funded by the Na tional Institutes of Health and re leased Wednesday at the annual meeting of the Society of Gyneco logic Oncologists, suggests that regular aspirin use for at least six months reduces the risk of epithe lial ovarian cancer. Epithelial ovarian cancer, the most common ovarian cancer, orig inates in the cells that cover the sur face of a woman’s ovary. Akhmedkhanov said his team’s research could affect the treatment and prevention of gynecologic cancers but that more research is needed. He studied aspirin — an anti-in flammatory — because chronic in flammation could be related to ep- wuje Brown 'Battalion If was a nig women’s ithelial ovarian cancer, asiti owever, it was dometriosis and pelvic intf: ere hoping fo ry disease. odores blitzed The study involved748« Hie loss drc enrolled in the New YorkL; id ends the 2 ty Women s Health Study# atcli win streal swered questions about thrive first top-10; use from 1994 to 1996. Oftl &m, improve developed epithelial ovarian mjwith their Among the cancer pane mjjUd Stanforc percent had used aspirin rep “Talent-wist Anion- the rest. 16percer;, elhvith lhcm ed regular aspirin use. is Coach Bobb I he researcher said L eat X n a lot of g< accountings for variables# hv hpn ° contraceptive use and fani; ^ ' cer history, he calculated t: uickl on ^ ular aspirin use could redi T risk of developing the cancer? 0 - 01 ’ Ul11 "' lajorie Terbui PC, The study was the fifth* f^to Vandei lationship between ovarian' , 1 and aspirin or other md Tsoobaoos * anti-inflammatory drugs. . an 0 c khanov said his was thefin:^ 0lbur ^ ’■ gin with*healthy participant' were followed over time, a res method considered more act. than a retrospective study. Akhmedkhanov’s study i triguing, said Dr. DuBois, director forgastroetj <n! Vanderbilt lhiiversityyl ical Center in Nashville,wt:: researched aspirin's relation# tv Jason Lingo colon cancer. H Aggi inBi he Battalion The Texas Ai California red-legged frog gets habitat designation FRESNO, Calif. (AP) — Celebrated for its jumping and protected for its scarcity, the California red-legged frog has won a critical habitat des ignation on more than 4 million acres of the state. But the protection does not cover the county where Mark Twain set “The Celebrated Jumping Frog of Calaveras County,” the classic 1865 short sto ry about a frog that could “get over more ground in one straddle than any animal of his breed you ever see.” The irony was not lost on federal officials who approved the final 4.1- ifrillion acre plan Tuesday. “We hope to work with many people in Calaveras County who have ex pressed to us they would like to have Mark Twain’s frog come home,” said Patricia Foulk of the U.S. Fish and Wildlife Service. , - The frog already was listed as “threatened,” but the new designation by the Fish and Wildlife Service exposes developers to greater federal scruti ny by mapping out where frog populations live or could recover. The government had to develop the habitat plan after environmental groups successfully sued, claiming the government had to declare a critical habitat for any species protected under the Endangered Species Act. The amphibians are considered an important indicator species of the health of aquatic areas. The frogs once numbered in the millions in California but now only four places are known to have populations greater than 350, said Peter Galvin, a conservation biologist for the Center for Biological Diversity. Africans may save on AIDS drug wn fell by sev nFeb. 17 in Co have to reve ler to keep its se he Phillips 66 E I The 11 th-see Merck pharmaceutical manufacturer to sell medications for zero ■L J J L J '.onference tour by-case basis, Reaves said. equivalent Sustiva costs $4,730 per patier:|emper Arena Reaves said the company is looking in particu- year, will be sold for $500 a year. ■The Big 1 lar at “those countries where clearly the disease is Merck said the treatments will beavailafetys an excitii most devastating, and also where economic con ditions are devastating.” Merck, one of the world’s biggest manufactur ers of AIDS drugs, makes Crixivan and Stocrin, TRENTON, N.J. (AP) — Pharmaceutical man ufacturer Merck & Co. announced that it will dras tically cut prices for two HIV drugs in AIDS-rav aged Africa and other developing parts of the world. In a statement Wednesday, the company said it will make no profit when selling the two protease- inhibitor drugs in developing countries. The drugs will be made available at about one-tenth of their U.S. price. Merck and other drug companies have come under sharp criticism from various governments and relief groups, which accuse them of keeping patented lifesaving medicines beyond the reach of the world’s poor. “The reason we did this is we’re trying to speed the process of access to these medicines,” said Merck spokesman Greg Reaves. “We thought it would now spur other entities to get involved.” More than 25 million of the 36 million peo ple infected with HIV live in sub-Saharan Africa, one of the world’s most impoverished regions. Developing countries in other areas will be eval uated for the reduced-price program on a case- u We thought it would now spur other entities to get involved” reduced price to governments, relief agenc: nvolved,” s others who can provide them to patients, Alelvin Watkii condition that the drugs be used only in the. to say it’s tries where they are sold. Ip that’s true. Protease inhibitors, introduced in record ar 1990s, revolutionized AIDS treatment, t”"' 1 ^ NCAA tou ing the disease from a death sentence into ai “That’s wha ageable chronic ailment for many patients, bat drugs typically are mixed with two other,5plv ia , ve a nc medicines such as AZT and 3TC. ■ The A S8 ICS — Greg Reaves Merck spokesman Officials with Doctors Without Bottol^toura which suppress HIV levels in the body and can be used alone or in drug combinations known as AIDS cocktails. Crixivan, which sells for $6,016 per patient per year in the United States, will be sold in develop ing countries for $600 a year; Stocrin, whose U.S. Nobel Peace Prize-winning relief agency, four seas(1 corned Merck’s announcement but cautionecL urne a AM the reduced price could still leave the drugs(. O f eac ^ ontest reach for many of Africa’s AIDS patients. ^ ven straight o “It’s also important that the person onthesJ|L es dating b who is working, but whose employer isn’tp; B for it, can go and get them,” said Toby Kasper, | works for the agency just outside Cape It South Africa. LUNEUf™ Monthly Contraceptive Injection medroxyprogesterone acetate and estradiol cyplonate Injectable suspension o/ lot] on to Injection Is LUNELLE™ Monthly Contracept (like all hormonal contraceptiv intended to prevent pregnancy. It does not protect against HIV Infection (AIDS) and other sexually transmitted • 0verage35andsmoke15ormore cigarettes per day Tell your health care provider if you have ever had any of these conditions. Your health care provider can recommend a safer method of birth control. ABE.THERE OTHER THINGS TO CON- MONTHLY CONTRACEPTIVE INJECTION? For the majority ol women, hormonal contracep tives can be taken safely. But there are some GIRL’S SOFTBALL UMPIRES WANTED Anyone interested in officiating girl's fast pitch soft ball. Assignments are available Monday through Saturday each week. Games are played from February through November. Pay ranges from $12.50 to $30.00 per game. Clinics, training, and testing are provided for each official. For more information call Mike Littlejohn at 776-5062, Terry Mix at 693-2958 or Tony Scazzero at 778-0133. ADULT SLOW-PITCH UMPIRES WANTED Monday-Thursday 6:15-10:15 and weekends. Games Feb. 19 - October. $8.00 to $ 12.00 per game. For mgpe information call Mike Littlejohn at 776-5062 or Terry Hix at 693-2958. This summary contains important Information about LUNELLE 1 " Monthly Contraceptive Injection. It is not meant to take the place of dis cussions with your doctor and It cannot replace your doctor’s advice. Only your doctor can assess the benefits and risks to decide if LUNELLE™ Monthly Contraceptive Injection is right for you. Talk to your doctor or pharmacist, or other pre scribing healthcare professional, if you do not understand any of lliis information or II you want to know more about LUNELLE™ Monthly Contraceptive Injection. WHAT IS LUNEUE™JllQNffllX£QXIRA: CEPTWEINJECTION? LUNELLE™ Monthly Contraceptive Injection is a lype of hormonal birth control that is given as an injection (a shot) in your arm, thigh, or buttock liver tumors can rupture and cause fatal internal of death Is always lower than that associated with ier or lighter, and there may be no bleeding, fewer 2. While breast feeding bleeding. In addition, a possible but not definite pregnancy lor any age group, although over (he days ol bleeding, or more days of bleeding than if you are breast feedino consult your health association has been found with hormonal contra- age ot 40, the risk increases to 32 deaths per what you have previously experienced. Such T Drov j(j er he( 0re startino hormonal contraceo- ceptives and liver cancSrs in Iwo studies, in which 100,000 women, compared to 28 associated with bleeding usually does not indicate any serious ^ iSno LUNRI F" 9 MonSv ^ a tew women who developed these very rare can- pregnancy at that age. However, lor oral hormonal problems. II an altered bleeding pattern persists or COTt'rarStaiOT&xrrdtttedruasinhor- cers were found to have used hormonal contra- contraceptive users who smoke and are over the the bleeding is severe, discuss it with your health on totte (Jttfoin ceptives lor long periods. However, liver cancers age ot 35, the estimated number ol deaths care provider. There is also a small risk that ™ are ^ on ™ ™ in are extremely rare. The chance of developing liver exceeds those for other methods of birth control, (painful) cramps may be associated with bleeding, cancer from using hormonal contraceptives is thus If a woman is over the age ot 40 and smokes, 2. Weight change even rarer. ■ her estimatKl risk of death is four times higher Weight gain is a common side effect in women women who are at high risk of developing certain 4, Cancer of the reproductive organs and (117/100,000 women) than Ihe estimated risk serious diseases that can be life-threatening or breasts may cause temporary or permanent disability. Tell There is, at present, no confirmed evidence that in that age group. (n /yiuu.uuu women) than Ihe estimated risk usinn LUNELLE™ Monthlv Cnnlramiiivp associated with pregnancy (28/100,000 women) injection. The average exp«ctS wight ^iii lin is 4 breast milk. A few adverse effects on the child have been reported, including yellowing of the skin (jaundice) and breast enlargement. In addi tion, hormonal contraceptives may decrease the amount and quality of your milk, to insure ihe tgf N milk, you your health care provider If you have: • Breast nodules, Fibrocystic disease of the breast, an abnormal breast x-ray or mammo- 8 ram, strong family history of breast cancer iabetes • Elevated cholesterol or triglycerides • High blood pressure • Migraine or other headaches or epilepsy • Mental depression Gallbladder, heart or kidney disease pounds in Ihe first year of use. Some women gain should wail until 6 weeks after childbirth before oral hormonalcontraceptives increase Ihe risk of An Mvisory Committee of the FDA discussed Jbis more than 10 to 20 pounds in the first year. you start using LUNELLE™ Monthly Contraoeplive ies. Studies to date of women taking Ihe pill have of oral contraceptive use by healthy, non-smoking lost as much as 48 pounds in one year ol use ceptives while breast feeding «||| —|| iw n|''"““‘"h the Clinical trials showed wide variability in individual Breast feeding provides only partial protection , KISH ftS'?! ^ 'hcreasmg percentage ol from becoming pregnant and this padial protec- LUNELLE Monlhly Contraceptive Injection users tion decreases significantly as you breast teed for experiencing weight change in excess of 10 and longer periods of time. You should use another continued treatment. method of contr 20 pounds with 3. Contact lenses It you wear contact tenses and notice a change in vision or an inability to wear your lenses, contact your doctor or health care provider. 4. Fluid retention 3 use the lowest dose oral contracep- pill use have found no overall increase in the risk live that is effective, and are strongly advised not ot developing breast cancer, although some stud- to smoke. ies have reported an increased risk of developing WHAT SYMPTOMS MAY SIGNAL PR0B- breast cancer in certain groups of women. LEMS WHILE USING LUNELLE™ 1 M0NTH- • History ot scanty or irregular menstrual periods Some studies have found an increase in the inci- LY CONTRACEPTIVE INJECTION? • Smoke, especially it 35 years or older dence ot cancer ot the cervix in women who use Call your doctor immediately it any ol these Women with any of these conditions should be oral hormonal contraceptives. However, this find- adverse effects occur while you are laking checked often by their health care provider if they ing may be related to factors other than the use of LUNELLE™ Monthly Contraceptive Injection, Hnmnnal mntrarwviw* m*, once a monttrto prevent pregnancy. It contains ^ ^^ELLE™ Monthly Contraceptive oral hormonal contraceptives. • Sharp chest pain, coughing of blood, or sudden retention) with swellino of the linners nr ankips am hormones which have effects similar to the natural Studies have found that women who used homones estrogen and progesterone produced A|S0 - be sure ,0 lnlorm V our t™ 0 ! or ft®* injectable hormonal contraceptives (Depo-Provera in your body. Similar combinations ot hormones Provider if you smoke or are on any medications. Contraceptive Injection) had no increased overall are found in some oral contraceptives also known WHAT ARE THE RISKS ASSOCIATED WITH risk of developing cancer of the breast, ovary, as "birth control pills" or Ihe pill," When you TAKING HORMONAL CONTRACEPTIVES? uterus, or cervix. However, women under 35 years receive your injections once a month as pre- 1. Risk ot developing blood clots, heart of age whose first exposure to Depo-Provera scribed, LUNELLE™ Monthly Contraceptive attacks, and strokes Contraceptive Injection was wiihm Ihe previous 4 Injection is as effective as birth control pills. When Blood clots and blockage of blood vessels are the 5 Y® 5 J^ve a slightly increased risk of given according to the prescribed schedule, most serious side effects ot taking hormonal con- d®'*teP in Q ot®® 51 cancer similar to that seen with LUNELLE" Monthly Contraceptive Injection is traceptives. In particular, blood clots can occur in oral contraceptives, effective in preventing pregnancy during Ihe cycle the legs and can travel to the lungs and can cause Women who use hormonal contraceptives and in which il is given. Clinical studies have shown sudden blocking of the vessel carrying blood to have a strong family history of breast cancer or bharp chest pain, coughing ol blood, or sudden ^jon) ^ J™ 0 f the finoers or ankles and “g)' “ (indica,ing 3 possible clot ^ KXraJ iyou experience I of contraception while breast feeding and consider starting hormonal contraceptives only after you have weaned your child completely. 3. Laboratory tests If you are scheduled for any laboratory tests, tell your doctor you are taking a hormonal contracep tive. Certain blood tests may be affected by hor monal contraceptives. 4. Drug interactions your menstrual bleeding. Even il you do not have any menstrual bleed ing, you should stiff return once a month for your injection of LUNELLE™ Monlhly Contraceptive Injection. It is important lhal you receive each ol your next injections ai the right time. If you cannot receive your injection on lime, contact your health care provider lo receive an earlier injection. What Happens If I Miss an Injection or Watt Longer than 33 Days Between Injections? • You could become pregnant if you miss your injection or wail longer than 33 days between injections. The more days you wail, the greater Ihe risk that you could become pregnant • Ask your health care provider lo recommend anolner type ot birth control (such as condoms or a spermicide) for you to use. • Talk with your health care provider lo find out when you should receive your next injection of LUNELLE™ Monlhly Contraceptive Injection. • Your health care provider may do a lesl lo make sure you are not pregnant before giving you your next injection ol LUNELLE™ Monthly Contraceptive Injection. Pregnancy Due to Failure w/th LUNELLE™ Monthly Contraceptive Injection The incidence ol failure with LUNELLE™ Monthly Contraceptive Injection resulting in pregnancy is Itein in foe calf (indicating a possible dot in the leg) U^^iion, Contact your doctor or heallh care teSl^Z'p»T/oO Crushing chest pain or heaviness in the chest L nthur j 6 ?, wro^P®'year) if given every month as directed possible heart attack) Kypu think trial you may .be pregnant be sure to iindicating a possible stroke) • Sudden partial or complete loss of vision MAKE MONEY THE OLD-FASHIONED WAY SELL SOMETHING. The Battalion Classifieds Call 845-0569 that when women receive LUNELLE" Monlhly Contraceptive Injection according to the recom mended schedule, the failure rate of this method of birth control is less than 1% per year. WHO SHOULD NOT TAKE EUNEUE™ MONTHLY ILY CONTRACEPTIVE INJECTION? Cigarette smoking increases the risk of serious cardiovascular side effects from hormonal contraceptive use. This risk Increases with age and with heavy smok- a (15 or more cigarettes per day) and is a marked in women over 35 years ol age. Women who use hormonal contra ceptives are strongly advised not to smoke. the lungs. Rarely, clots occur in the blood vessels whohave breast nodules or abnormal mammo- of the eye and may cause blindness, double vision, or impaired vision. If you take hormonal contraceptives such as LUNELLE™ Monthly Contraceptive Injection and need elective surgery, need to stay in bed tor a prolonged illness, or have recently had a baby, gram should be closely followed by their doctors. 5. Changes in bone mineral density Use of injectable hormonal contraceptives con taining Ihe progesterone-type hormone found in LUNELLE™ Monthly Contraceptive Injection may be associated with a decrease in the amount of spverphrafbrhp m vnmit nn riimrvKc 0,,le, si<)e e,lec ts ^ include breast pain or ten- Such drugs include aminoglutethimide, rifampin, or fainiino disturbances of vision or sneerh denless ' ^ chan 3 e in Wtite, nausea, headache, drugs used for epilepsy such as barbiturates (tor weakness’or numbness in an arm nr ten C ’ nervousness, depression, mood changes, changes example, phenobarbital), carbamazepine, and ' n D ess 1 armoneg insexualdesire,dizziness, loss of scalp hair, rash, phenytoin (Dilantin is one brand of this drug), and vaginal infeciions. If any of these side effects phenylbutazone (Butazolidin is one brand), Fierbal bother you, caff your health care provider. products containing St. John’s Wort (hypericum lumps hndlraiina'possibie'"Mast cancer WHAT PRECAUTIONS SH0ULP.QL perforatum), and possibly certain antibiotics. You or fibrS K of Ibe b ^1 XS FOLLOWED OURING USE OF LUNELLE? may need lo use an additional contraception alsKr"*” 5 " sssstsss. Sfwrefainwienrtenessinineabdtmnal trawiffimbstoreordurin.pnjfliiaiicy area (indicating a possibly ruptured liver tumor, You may not mgnstruate regularly after you LUNELLE™.Monlhly Contraceptive Injecti espec y if you tad i egular ovarian cyst, or pregnancy outside the uterus) receive an injerjon of LUNELLE™ Monthly Sexually transmitted diseases call your health care provider. What III Want to Become Pregnant? You will need lo stop your monlhly injections of LUNELLE™ Monlhly Contraceptive Injedion. Most women begin lo produce eggs again (and could become pregnanl) about Iwo to Ihree months afct their Iasi injection. There may be some delay in becoming pregnant before you started using il contraceptives. you may be at risk of developing blood clots. You mineral stored in your bones, ftiis could increase UCMICM|UI|; Si * SM^q^nTiKaTgSL 5, receiving injectable contapiive's as scheduled is diseases such as chlamydia.genital her- ct iitwu anti nru haVmn hnmvmai mnfrar'ontiuoQ iranftoisimnf mniranentive hi il after that of appetite, dark-colord urine, or light-colored very low, If you have not received your injections pes, genital warts, gonorrhea, hepatitis B, bowel movements (indicating possible liver as scheduled and missed a menstrual period, or il and syphilis. surgery and not taking hormonal contraceptives use of this lype of contraceptive, but after that, it for two weeks after surgery or during bed rest. You begins to resemble the normal rate of age-related should also not take hormonal contraceptives bone mineral loss, soon after delivery of a baby. It is advisable lo wait 6. Allergic reactions The risk of unexpected pregnancy for women HIV (AIDS) and other sexually transmitted ■I injectable con WHATSHOULDIKNOWABOUTA POSSIBLE QVERDQSE OF LUNELLE!" Some women should not use hormonal contra- for at least four weeks after deliv hormonal contraceptives such as LUNELLE™ Severe allergic reactions have been reported in some women using injectable hormonal contra- ' ehor- problems) you missed two consecutive menstrual periods, 6. Weight change • fosistent pain, pus, or bleeding at the injection site yon rnay be preflnant. Check with your health care LUNELLE™ Monthly Contraceptive Injection may • Unusually heavy vaoinal bleedina provider immediately lo determine whether you cause weioW oain of more than 10 pounds. b pregnant or think you may be pregnant. " ' )t use LUNELLE™ Monthly should also not i Contraceptive Injection if you have any of the fol lowing conditions: ' A history of heart attack or stroke id clot • Blood clots in Ihe legs (thrombophlebitis), lungs (pulmonary embolism), or eyes • A history of blood clots in the deep ve your legs • Chest pain (angina pectoris) > Known or suspected breast cancer or cancer USE OF LUNELLE MONTHLY CONTRACEPTIVE INJECTION?) Hormonal contraceptives may also increase the y to develop strokes (stoppage or rupture ceptives containing the progesterone-type mone found in LUNELLE™ Monthly Contraceptive TiuFTiiciFTTinw? Injection. Allergic reactions occurring in women i wJ n in5hiooIiinn using LUNELLE™ Monthly Contraceptive Injection " a ' b ' " , Unusually heavy vaginal bleeding WHAT ARE THE POSSIBLE SIDE EFFECTS OF LUNELLE " MONTHLY CONTRACEP- have"been mainly skin reactions, and not respira- Most 'women using LUNELLE™ Monthly lory in nature. Serious allergic reactions require o l !fy erlel ^ allerallon of .... . emergency medical treatrrwit. ? en ^ ll l leedln ? h , B tt 9 1 pa * e L , ^? ayv ? , >„ of blood vessels in the brain) and angina pectoris fshmatfd risk of ofath frrm a birth "On}, 3 .single monthly bleed to no bleeding at all and heart attacks (blockage of blood vessels in the CONITOL MEffiOD OR PREGNANCY 111 2 r sll9ht stainin9 belwmi mens,rial pe,iods 10 veins of heart). Any of these conditions can cause death or All methods of birth control and frequent, prolonged, and/or unpredictable bleed- the lining ot the uterus, cervix or vagina • Unexplained vaginal bleeding (until a diag nosis Is reached by your doctor) • Yellowing of the whites ot the eyes or of the skin (jaundice) during pregnancy or during previous use ot the pill or other hormonal contraceptives provider immediately lo determine whether you cause weight gain of more than 10 pounds, are pregnant. Do not continue the injections until WHEN DO I GET MY LUNELLE™ 1 MONTH- you are sure you are not pregnant, but use another [_y CONTRACEPTIVE INJECTION? method ot contraception. LUNELLE 1 " Monthly Contraceptive Injection can There is no conclusive evidence lhat oral hormonal only be effective if you receive your injections at contraceptive use is associated with an increase in ihe proper times, birth defects, when taken inadvertently during early ff/sf Injection within the first 5 days of the start of your normal menstrual period. It you are presently using another type of birth control, your heallh care provider will decide the best time for you to start LUNELLE™ Monthly Conlraceptive Injection. This will help make sure you have continued conlraceptive coverage. If you have recently been pregnant oi had a effects have not been reported lolkmiiig ingestion of large doses of oral horrnonal contraoepftes by young childien. Ovendosage may cause nausea and withdraval bleeding in temales. In case ol ovetdosage conlacl your heallh care provider or pharmacist Keep this and all drugs out of the reach ot children. OTHEHJNFORMATIQN Your heallh care provider will lake a medical and family history before prescribing hormonal conlraceplives. You should receive yearly physical examinations by your heallh care provider. Be sure to inform your health care provider if there is a family history of any ol the conditions listed previ ously in Ibis leaffet. Be sure to keep all appoint ments with your health care provider, because Ibis is a lime to determine if there are early signs ol side effects ol hormonal contraceptive use. If you • liver tumor (benign or cancerous) • Known or suspected pregnancy • Allergy to any of Die ingredients contained in LUNELLE™ Monthly Contraceptive Injection pregnancy. Nevertheless, hormonal contraceptives should not be used during pregnancy. With Depo-Provera Contraceptive Injection, there have been reports of an increased risk of low birth weight and neonatal infant death or other health «asorKsasassss*- SaaaSSff s^aisassa. KXsasKiss pstaffpissr of developing and dying of heart disease, particu- Th e risk of death from anv birth control melhnrt is ln 42% of women durin9 lhe ,irsl monlh 01 use c . or | t,ace P ,lve Injection (MPA), and followed to larlyil you are over 35 years of age. l^tatt^sko^^feeStfoSta- and in 29% of women at the end ot one year ol adolescence.showed no evidence of any adverse 2. Gallbladder disease irorKn^tiw^rs wlteMe of I who S ln , any 9lven in|f ? tion interval, approximately efe* on their health including their physical, Hormonal contraceptive users probably have a smoke and oral hormonal contraceptive users al i and ' ° r 500131 devel0Dmfrt greater risk than non-users ol having gallbladder over the age of 40 even if they do not smoke. For varh S mwr ifunnumoa »r«*«wt>«isisar ssraz'KKlrSZ"" “-s women. Your menstrual blood flow may be heav- tion taken during pregnancy. nu j 0 J 3 *? 51 ?*. your P revlou 1 s , iLwl monthly cotllraceplive in edlOfl injection, and not by the liming or amount ol m<h*»|]nigKt8nmac8t®8^ want more information about hormonal contracep tives, ask your health care provider or pharmacist . „ . . . .. for a more technical leallet called the Prescribing baby, discuss with your^heatth care provider the information that you may wish to read. Rx only: Manufactured by: best time for you to start LUNELLE™ Monthly Contraceptive Injection. Acct 230 Econ 202 Dr. Alien Econ 322 Einc 309 Math 142 Math 151 Math 152 Mgmt 211